Back to top

Oncolytics Biotech advances REO 033 colorectal cancer program

Oncolytics Biotech ( ($ONCY) ) has provided an announcement. On July 13, 2026, Oncolytics Biotech reported clinical and regulatory progress for its...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Oncolytics Biotech Inc. (ONCY)